Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting? Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015
Clinical management of lung cancer in France: a national survey Source: Eur Respir J 2001; 18: Suppl. 33, 228s Year: 2001
Screening for incidence of lung cancer (LC) among the patients with pulmonary pathology (with special reference to histological subtype and TNM-staging system) in Ukraine Source: Eur Respir J 2005; 26: Suppl. 49, 537s Year: 2005
Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patients Source: International Congress 2015 – Quality management in lung cancer Year: 2015
Cytological specimens' relative contribution in establishing histological diagnosis of lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014
A regional study of bronchoscopic diagnostic yield rates for lung cancer involving centres of the Thames Valley Cancer Network (TVCN), UK Source: Annual Congress 2010 - The role of endoscopy in the diagnosis of lung cancer Year: 2010
The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection Source: Eur Respir J 2002; 20: 464-479 Year: 2002
Pathology of lung cancer: histology, cytology, immunohistochemistry and molecular pathology Source: Eur Respir Mon; 2010: 48: 272–296 Year: 2010
Systematic and combined endosonographic staging of lung cancer (SCORE study) Source: Eur Respir J, 53 (2) 1800800; 10.1183/13993003.00800-2018 Year: 2019
Hospitalization costs of lung cancer diagnosis in Turkey: Is there a difference between histological types and stages? Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015
ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Eur Respir J, 52 (6) 1800610; 10.1183/13993003.00610-2018 Year: 2018
ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Guideline 2018 Year: 2018
ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018
Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014
Significance of age, tumor location and histological subtype in lung cancer with brain metastasis Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013
Should resection rate increase when PET-CT use increases? An analysis of PET-CT use in large UK lung cancer network 2011 - 2013 Source: International Congress 2015 – Quality management in lung cancer Year: 2015
Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021
Second primary lung cancer in squamous NSCLC patients: The Nancy Biobank's database Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014
Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013